CLBS - Caladrius Biosciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts2232
Avg. Estimate-0.43-0.49-1.86-1.5
Low Estimate-0.5-0.54-1.97-2.14
High Estimate-0.36-0.45-1.7-0.86
Year Ago EPS-0.36-0.36-1.67-1.86
Revenue EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts2232
Avg. EstimateN/AN/AN/A5M
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/A10M
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History9/29/201812/30/20183/30/20196/29/2019
EPS Est.-0.56-0.44-0.42-0.44
EPS Actual-0.36-0.36-0.44-0.49
Difference0.20.08-0.02-0.05
Surprise %35.70%18.20%-4.80%-11.40%
EPS TrendCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.43-0.49-1.86-1.5
7 Days Ago-0.43-0.49-1.86-1.5
30 Days Ago-0.43-0.49-1.86-1.5
60 Days Ago-0.45-0.47-1.84-1.31
90 Days Ago-0.45-0.47-1.84-1.31
EPS RevisionsCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesCLBSIndustrySectorS&P 500
Current Qtr.-19.40%N/AN/A-0.01
Next Qtr.-36.10%N/AN/A0.07
Current Year-11.40%N/AN/A-0.01
Next Year19.40%N/AN/A0.14
Next 5 Years (per annum)60.00%N/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A